Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-01-22 | 2021-02-25 | 132254 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2021-01-22 | 2021-03-18 | 132257 |
| TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2021-01-22 | 2021-09-02 | 132261 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-22 | 2021-04-21 | 132264 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2021-01-22 | 2021-02-11 | 132267 |
| TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2021-01-22 | 2021-03-11 | 132273 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2021-01-22 | 2021-05-06 | 132276 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132282 |
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132285 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132288 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2021-01-22 | 2021-02-12 | 132294 |
| TEVA-TOPIRAMATE | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-11 | 132649 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-01-28 | 2021-05-20 | 132652 |
| TEVA-CANDESARTAN/HCTZ | 32MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132657 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-28 | 2021-04-29 | 132660 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132663 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-25 | 132666 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-02-05 | 2021-03-11 | 133448 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2021-02-05 | 2021-03-11 | 133453 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2021-02-05 | 2023-06-09 | 133460 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |